Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 33 citing articles:

Recent Updates of Transarterial Chemoembolilzation in Hepatocellular Carcinoma
Young Woon Chang, Soung Won Jeong, Jae Young Jang, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8165-8165
Open Access | Times Cited: 234
Usefulness of neutrophil-to-lymphocyte ratio (NLR) as a prognostic predictor after treatment of hepatocellular carcinoma." Review article
Mohamad Mouchli, Shravani Reddy, Miranda Gerrard, et al.
Annals of Hepatology (2020) Vol. 22, pp. 100249-100249
Open Access | Times Cited: 92
Prognostic Role of Neutrophil-to-Lymphocyte Ratio (NLR), Lymphocyte-to-Monocyte Ratio (LMR), Platelet-to-Lymphocyte Ratio (PLR) and Lymphocyte-to-C Reactive Protein Ratio (LCR) in Patients with Hepatocellular Carcinoma (HCC) undergoing Chemoembolizations (TACE) of the Liver: The Unexplored Corner Linking Tumor Microenvironment, Biomarkers and Interventional Radiology
Roberto Minici, Maria Anna Siciliano, Michele Ammendola, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 257-257
Open Access | Times Cited: 45
The Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab
Jing‐Houng Wang, Yen‐Yang Chen, Kwong‐Ming Kee, et al.
Cancers (2022) Vol. 14, Iss. 2, pp. 343-343
Open Access | Times Cited: 35
The prognostic value of the preoperative inflammatory index on the survival of glioblastoma patients
Xiaohan Shi, ·Huayu Li, Yongxiang Xu, et al.
Neurological Sciences (2022) Vol. 43, Iss. 9, pp. 5523-5531
Open Access | Times Cited: 20
Correlation between Serological Biomarkers and Disease Activity in Patients with Inflammatory Bowel Disease
Mengque Xu, Mengsha Cen, Xiaoli Chen, et al.
BioMed Research International (2019) Vol. 2019, pp. 1-7
Open Access | Times Cited: 32
The significance of osteosarcopenia as a predictor of the long‐term outcomes in hepatocellular carcinoma after hepatic resection
Mitsuru Yanagaki, Koichiro Haruki, Tomohiko Taniai, et al.
Journal of Hepato-Biliary-Pancreatic Sciences (2022) Vol. 30, Iss. 4, pp. 453-461
Closed Access | Times Cited: 18
Prognostic significance of inflammatory indices in hepatocellular carcinoma treated with transarterial chemoembolization: A systematic review and meta-analysis
Shuangshuang Li, Xudong Feng, Guodong Cao, et al.
PLoS ONE (2020) Vol. 15, Iss. 3, pp. e0230879-e0230879
Open Access | Times Cited: 24
Prognostic value of preoperative inflammatory markers in patients with hepatocellular carcinoma who underwent curative resection
Wenlong Wu, Quancheng Wang, Dandan Han, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 23
Which is the best TACE agent for patients with different NLR hepatocellular carcinomas? A systematic review and network meta-analysis
Shuai Wang, Hefeng Geng, Yizhen Li, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30759-e30759
Open Access | Times Cited: 3
<p>Prognostic significance of lymphocyte-to-monocyte ratio and platelet-to-lymphocyte ratio in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization and radiofrequency ablation</p>
Yanjun Shen, Huige Wang, Xiangmei Chen, et al.
OncoTargets and Therapy (2019) Vol. Volume 12, pp. 7129-7137
Open Access | Times Cited: 24
Prognostic prediction of the platelet-to-lymphocyte ratio in hepatocellular carcinoma: a systematic review and meta-analysis
De-Zhao Li, Jia Guo, Qingkun Song, et al.
Translational Cancer Research (2022) Vol. 11, Iss. 11, pp. 4037-4050
Open Access | Times Cited: 13
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Predictors of Outcomes in Patients With Unresectable Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Plus Sorafenib
Lei Zhang, Zhiping Yan, Zhong-Heng Hou, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 16
Assessment of the Clinical Value of Platelet-to-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma
Xu Chen, Abdul Mohammed, Chengbin Li
Clinical and Applied Thrombosis/Hemostasis (2024) Vol. 30
Open Access | Times Cited: 2
<p>Dynamic Changes in the Neutrophil-to-Lymphocyte Ratio Predict the Prognosis of Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization</p>
Hongyu Wang, Chuyang Lin, Wenzhe Fan, et al.
Cancer Management and Research (2020) Vol. Volume 12, pp. 3433-3444
Open Access | Times Cited: 16
The Significance of the Rapid Turnover Protein Score as a Predictor of the Long-Term Outcomes in Hepatocellular Carcinoma After Hepatic Resection
Mitsuru Yanagaki, Koichiro Haruki, Jungo Yasuda, et al.
Annals of Surgical Oncology (2021) Vol. 28, Iss. 13, pp. 8130-8139
Closed Access | Times Cited: 14
Inflammatory Scores: Comparison and Utility in HCC Patients Undergoing Transarterial Chemoembolization in a North American Cohort
Shamar Young, İsa Çam, Mehmet Gençtürk, et al.
Journal of Hepatocellular Carcinoma (2021) Vol. Volume 8, pp. 1513-1524
Open Access | Times Cited: 13
The prognostic values of serum markers in hepatocellular carcinoma after invasive therapies based on real‐world data
Bo Li, Aixia Liu, Yi Wen, et al.
Journal of Clinical Laboratory Analysis (2021) Vol. 35, Iss. 9
Open Access | Times Cited: 12
The prognostic significance of inflammation-based scores in patients with ampullary carcinoma after pancreaticoduodenectomy
Shuxin Sun, Chaobin He, Jun Wang, et al.
BMC Cancer (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 12
Prognostic impact of osteosarcopenia in patients undergoing pancreatic resection for pancreatic ductal adenocarcinoma
Mitsuru Yanagaki, Shinji Onda, Takeshi Gocho, et al.
Langenbeck s Archives of Surgery (2024) Vol. 409, Iss. 1
Closed Access | Times Cited: 1
Predictive Value of Preoperative Serum AFP, CEA, and CA19-9 Levels in Patients with Single Small Hepatocellular Carcinoma: Retrospective Study
Leijuan Gan, Shaohua Ren, Mengran Lang, et al.
Journal of Hepatocellular Carcinoma (2022) Vol. Volume 9, pp. 799-810
Open Access | Times Cited: 7
Immune Effects of Intra-Arterial Liver-Directed Therapies
Anita Karimi, Hooman Yarmohammadi, Joseph P. Erinjeri
Journal of Vascular and Interventional Radiology (2024) Vol. 35, Iss. 2, pp. 178-184
Open Access | Times Cited: 1
Combination of the gamma-glutamyltransferase-to-prealbumin ratio and other indicators may be a novel marker for predicting the prognosis of patients with hepatocellular carcinoma undergoing locoregional ablative therapies
Qi Wang, Peng Zhao, Ning He, et al.
Infectious Agents and Cancer (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Neutrophil-to-lymphocyte ratio as a prognostic biomarker in hepatocellular carcinoma after transarterial chemoembolization
Soung Won Jeong
Annals of Translational Medicine (2020) Vol. 8, Iss. 18, pp. 1124-1124
Open Access | Times Cited: 4
The Pretreatment Neutrophil-to-Lymphocyte Ratio (NLR) as a Near-term Prognostic Indicator in Patients with Locally Advanced Hepatocellular Carcinoma Treated with Hepatic Artery Infusion Chemotherapy: A Propensity Score Matching Cohort Study
Weifu Liu, Kongzhi Zhang, Shiguang Chen, et al.
Research Square (Research Square) (2024)
Open Access
Page 1 - Next Page

Scroll to top